Abstract
Dialysate calcium concentration (d[Ca]) might have a cardiovascular impact in patients on haemodialysis (HD) since a higher d[Ca] determines better hemodynamic tolerability. We have assessed the influence of d[Ca] on global longitudinal strain (GLS) by two-dimensional echocardiography using speckle-tracking imaging before and in the last hour of HD. This is an observational crossover study using d[Ca] 1.75 mmol/L and 1.25 mmol/L. Ultrafiltration was the same between interventions; patients aged 44 ± 13 years (N = 19). The 1.75 mmol/L d[Ca] was associated with lighter drop of blood pressure. Post HD serum total calcium was higher with d[Ca] 1.75 than with 1.25 mmol/L (11.5 ± 0.8 vs. 9.1 ± 0.5 mg/dL, respectively, p < 0.01). In almost all segments strain values were significantly worse in the peak HD with 1.75 mmol/L d[Ca] than with 1.25 mmol/L d[Ca]. GLS decreased from −19.8 ± 3.7% at baseline to −17.3 ± 2.9% and −16.1 ± 2.6% with 1.25 d[Ca] and 1.75 d[Ca] mmol/L, respectively (p < 0.05 for both d[Ca] vs. baseline and 1.25 d[Ca] vs. 1.75 d[Ca] mmol/L). Factors associated with a worse GLS included transferrin, C-reactive protein, weight lost, and post dialysis serum total calcium. We concluded that d[Ca] of 1.75 mmol/L was associated with higher post dialysis serum calcium, which contributed to a worse ventricular performance. Whether this finding would lead to myocardial stunning needs further investigation.
Similar content being viewed by others
Introduction
Patients with chronic kidney disease (CKD) on dialysis have a high cardiovascular risk and mortality rates1 that are not fully explained by classical risk factors such as hypertension, left ventricular (LV) hypertrophy, and diabetes2. Haemodialysis (HD) treatment might drive the high cardiovascular mortality, marked by sudden cardiac death and heart failure3 and, indeed, HD per se, is a cardiovascular stressor that can precipitate recurrent myocardial ischemia (HD-induced myocardial stunning), leading to the development of LV dysfunction, myocardial hibernation and fibrosis, culminating in heart failure4.
Two-dimensional speckle tracking imaging (STI) with 2D strain analysis is a more sensitive method than conventional echocardiography for subtle LV dysfunction assessment5,6,7. This technique is also considered a more powerful predictor of mortality in the general population8 and among patients on HD9. LV global peak systolic longitudinal strain (GLS), obtained from 2D strain analysis, is the ratio of the maximal change in myocardial longitudinal length in systole to the original length. LV myocardium shortens during systole in the longitudinal direction. Accordingly, GLS has a negative value, and a less negative GLS value indicates worse global LV systolic function6,10.
HD-induced regional LV dysfunction has been associated with high volumes of ultrafiltration, and it can be alleviated by cooling dialysate11 or by more frequent haemodialysis12. These results suggest that a better hemodynamic tolerability might potentially avoid regional LV dysfunction. HD can impair diastolic LV function, and studies yield contradictory results on the effect on systolic function13,14.
Calcium in cardiomyocytes is the key element of excitation-contraction coupling, so that hypercalcemia impairs the relaxation15. However, the influence of dialysate calcium concentration - d[Ca] is still overlooked and based on simple echocardiogram16,17. Since there is no consensus on the ideal d[Ca], there is great variability of choice among countries, mostly 1.25 mmol/L in the United States and >1.25 mmol/L in Europe, Australia and Latin America18. The d[Ca] might impact the left ventricular behavior during dialysis, as while a higher concentration determines better hemodynamic tolerability19, it can also induce a greater impairment on the left ventricular relaxation16. In the current study, we conducted a prospective cross-over study to ascertain whether d[Ca] would have an impact on GLS during HD.
Results
Baseline characteristics
We initially invited 23 patients to participate, but after 4 exclusions due to poor echocardiogram image quality, 19 patients were included. Clinical and demographic characteristics of the patients are shown in Table 1. Ten patients (52.6%) were considered nourished according to 7-point scale subjective global assessment (SGA), whereas 9 (47.4%) were classified as having mild/moderate undernourishment. Nourished patients presented lower transferrin [157 (132,177) vs. 174 (162, 190), p = 0.024]. Eight patients (42.1%) presented LV hypertrophy and LV ejection fraction (LVEF) were preserved in all patients (66.7 ± 3.7%).
Effect of d[Ca] on hemodynamic and biochemical parameters
Comparing both HD sessions with d[Ca] 1.25 and 1.75 mmol/L, the ultrafiltration was the same (3063 ± 534 mL), and weight loss was similar (−2.7 ± 0.8 vs. −2.6 ± 0.6 kg, respectively; p = 0.653), as were pre-dialysis weight, systolic, diastolic and mean blood pressure (MBP).
HD promoted several changes in blood pressure and biochemical parameters. The use of d[Ca] 1.75 mmol/L was associated with a slight drop only in systolic blood pressure and with an increase in serum calcium when compared to d[Ca] 1.25 mmol/L (Table 2). Calcium mass transfer was more positive with d[Ca] 1.75 than 1.25 mmol/L [906 (221; 1,907) mg and 165 (−27; 1,006) mg, respectively, p = 0.023].
Baseline GLS
Baseline GLS was −19.8 ± 3.7, ranging from −26.1 to −10.4%, and it was correlated with transferrin (r = −0.648, p = 0.007), troponin (r = 0.573, p = 0.050), and aldosterone (r = −0.555, p = 0.017), and there was also a trend towards a correlation with albumin (r = −0.426, p = 0.078) and alpha-2 macroglobulin (r = −0.448, p = 0.062). There was no difference on baseline GLS when comparing well-nourished and mild/moderately undernourished patients (−20.7 ± 3.0 vs. −18.9 ± 4.4, respectively; p = 0.302).
Segmental longitudinal strain
Segmental longitudinal strain values were significantly worse in the peak of HD with d[Ca] 1.75 mmol/L compared to baseline in almost all segments (Table 3).
GLS at the peak of haemodialysis
GLS was worse at the peak of HD compared to baseline (p < 0.001), and it was even worse with d[Ca] of 1.75 than 1.25 mmol/L (−16.1 ± 2.6% vs. −17.3 ± 2.9%, respectively; p < 0.001) (Fig. 1). An example of echocardiogram images illustrating GLS at baseline and at the peak of both HD with d[Ca] 1.25 mmol/L and d[Ca] 1.75 mmol/L is shown in a Bull’s eyes graphical representation in Fig. 2.
GLS at the peak of HD correlated with baseline GLS (r = 0.554, p < 0.001), transferrin (r = −0.599, p < 0.001) and C-reactive protein (r = 0.407, p = 0.012). The correlation with parathyroid hormone (PTH) was non significant (r = 0.304, p = 0.064).
Mean GLS variation from baseline to the peak of HD (GLS-change)
Regardless of d[Ca], while analyzing the entire population, GLS-change was 3.15 (1.35, 5.38), ranging from −3.80 to 9.50. GLS-change correlated with baseline GLS (r = −0.635, p < 0.001), aldosterone (r = 0.503, p = 0.002), weight loss during dialysis (r = −0.524, p < 0.01), and ultrafiltration (r = 0.553, p < 0.001). There was a trend toward a correlation with albumin (r = 0.309, p = 0.063) and troponin (r = −0.307, p = 0.092). Neither blood pressure nor calcium balance correlated with GLS-change.
High PTH subgroup analysis
Patients with a PTH higher than 300 pg/mL when compared to the remaining group presented worse GLS at the peak of dialysis (above the median), regardless the d[Ca] (78.9% vs. 21.1% with PTH > 300 mpg/mL and ≤300 pg/mL, respectively, p = 0.009), which represents a 6.5-fold higher risk. Multivariate linear regression analysis showed that GLS at the peak of HD was dependent on transferrin, C-reactive protein and higher post dialysis serum calcium that together explained 66.7% of the variability in GLS (Table 4). GLS-change was worse among patients with PTH > 300 pg/mL than in those with PTH ≤ 300 pg/mL [4.35 (2.5, 6.1) vs. 2.15 (−0.45, 3.18) pg/mL, respectively; p = 0.019], regardless the d[Ca].
Discussion
Our study provides new insights into the pathogenesis of LV dysfunction on conventional HD, showing an association with the dialysate calcium concentration. We have demonstrated that, despite the relatively better hemodynamic stability with d[Ca] 1.75 mmol/L, this dialysis bath was associated with worsening GLS at the peak of HD, which seems to be related to a higher serum calcium after the procedure. In addition, our data suggest that levels of PTH > 300 pg/mL might also represent a high risk of HD-induced myocardial ischemia, suggesting this hormone might increase the risk of myocardial stunning, although whether this is an independent risk factor warrants further investigation.
We have included a relatively young population, with preserved ventricular function, receiving adequate dose of dialysis, on regular thrice-weekly hemodialysis. Even in this clinical scenario, we observed a compromised ventricular function during hemodialysis, particularly when using d[Ca] of 1.75 mmmol/L, independent of ultrafiltration and blood pressure dropping. Our results, however, should be interpreted with caution since we studied a small sample size.
GLS is a more sensitive predictor for all-cause mortality than LVEF in the general population20. Liu and cols. have recently showed that a less negative GLS (defined as GLS ≥ −15%) predicted all-cause and cardiovascular (CV) mortality in HD patients with preserved LVEF21. Another study that enrolled 183 patients who were followed for 7.8 ± 4.4 years demonstrated that worsening GLS was independently associated with a higher all-cause and CV mortality in patients with stage 4, 5 CKD who were on HD22. A recent study has used magnetic resonance imaging to examine acute effects of standard HD versus hemodiafiltration in stable patients and, similarly to our findings, showed that all patients experienced some degree of segmental left ventricular dysfunction23. Interestingly, in the mentioned study by Buchanan C. et al.23 the d[Ca] was 1.5 mmol/L, which was not tested in the current study.
The association between d[Ca] and mortality in HD patients is still debatable. Data of The Dialysis Outcome Practice Pattern Study (DOPPS) have shown that high serum calcium was associated with increased all-cause mortality in HD patients24. Similarly, a recent observational study has demonstrated that HD with d[Ca] 1.75 mmol/L was associated with increased all-cause mortality compared with HD with d[Ca] 1.25 mmol/L25, which is not a unanimous finding26, since authors have demonstrated that a very low d[Ca] (<1.25 mmol/L) can be associated with an increased risk of sudden cardiac arrest, instead27.
The positive calcium balance generated from a high d[Ca] might contribute to increased mortality in HD patients, since a repeated exposure to calcium load has been associated with arterial calcification and stiffness28, which are associated with an increased risk of mortality in these patients29. The ideal dialysate calcium concentration is probably still unknown. However, data from the literature show that high d[Ca] has also been associated with high sympathetic stimulus during HD30, which might impact long-term mortality31. Kidney Disease Outcomes Quality Initiative (K/DOQI) guidelines have recommend a prescription of low d[Ca] to maintain neutral calcium balance and reduce vascular calcification32. However, reducing calcium load during HD may lead to a decreased hemodynamic stability through changes in systemic vascular resistance and/or cardiac output33. In the current study, we have tested the hypothesis that the d[Ca] would directly influence LV dysfunction because higher concentrations lead to a better hemodynamic tolerability19,34 and because it is related to a higher sympathetic activity30, whereas lower concentrations do the opposite. We found that 1.75 mmol/L d[Ca] was associated with a higher post dialysis serum calcium and worse GLS. We can speculate that since blood flow into the coronary arteries is greatest during ventricular diastole, higher d[Ca] could caused an impairment of coronary flow reserve. Ineffective vasoregulation predisposes the body to myocardial ischemia, which is already compromised in patients on dialysis35. The fact we found the association between a worse GLS with post dialysis serum calcium but not with calcium balance is still debatable. Our results suggest that, at least for the myocardial performance, serum calcium has a stronger impact than the calcium balance. Moreover, a positive calcium balance does not necessarily mean an increase in serum calcium, as the skeleton might act as a continuous buffering, mainly in those patients with higher serum PTH36. Our study emphasizes the need to elucidate the independent role of serum calcium and d[Ca] on the ventricular dysfunction and whether this contributes to myocardial stunning and increasing mortality risk in dialysis patients.
Elevated troponin concentration is associated with high mortality in dialysis patients20,37,38, even in patients with preserved LVEF21. High troponin levels are clearly associated with cardiac structural and functional damage, as LV hypertrophy, LV dilation, and systolic and diastolic dysfunction39. Our results showed an association between less negative baseline GLS and increased troponin concentration, which were consistent with a previous study21, and may reflect the presence of subtle LV dysfunction, detected by GLS, and subclinical myocardial injury resulting in the increase of troponin. Dialysis-induced myocardial stunning probably plays a role in this process, leading to systolic dysfunction, as demonstrated by McIntyre and cols4, showing a less negative GLS. Furthermore, it has been associated with high troponin levels40.
The correlations we found between GLS at the peak of HD and inflammation was already described12. We have confirmed this finding by showing a correlation between GLS at the peak of HD and C-reactive protein and extending the association with another inflammatory marker, the alpha-2 macroglobulin. Nutritional status has been associated with the risk of HD-induced myocardial stunning41. We found a correlation between GLS and serum transferrin, a sensitive marker for nutritional status and marker of protein-energy wasting42. Transferrin has a shorter half-life compared with albumin, which gives it a theoretical advantage as a nutrition marker. Despite this finding, we did not confirm a correlation between GLS and other markers of nutritional status such as albumin. In addition, there was no difference on baseline GLS when comparing well-nourished and mild/moderately undernourished patients.
PTH, a calcium regulator hormone, is also a depressive myocardial factor. We found that PTH, indeed, had an influence on the delta of GLS, which was worse in patients with levels of PTH higher than 300 pg/mL. Uremia, PTH and phosphate were already implicated in the cardiac remodeling process in CKD43. Based on this knowledge, we can postulate that PTH might have a direct effect on the myocardial response during HD. On the other hand, indirect effects of PTH can be noted since parathyroidectomy status34 and levels of PTH36 can interfere with hemodynamic changes and calcium balance during a conventional HD.
The present study has a unique strength in showing, for the first time, an influence of d[Ca] on HD-induced ventricular dysfunction, measured by GLS. In addition, this study has been conducted keeping constant ultrafiltration rate and a low temperature, which allowed the study of d[Ca] as an independent risk factor, and the study was single-blinded and prospective. Despite these strengths, the results of our study need to be interpreted in light of its limitations. There was only a single HD studied, the carry-on effect between the interventions could not be completely discarded, the sample size was relatively small, and we cannot guarantee that body temperature was stable in all patients during the 2 interventions. Patients included in the study are relatively young, with reasonable cardiac function, and therefore our results should be confirmed in larger population before can be widespread. In addition, we cannot exclude the possibility that our findings are confounded by factors that we could not ascertain, such as the hydration status.
In summary, we have demonstrated that a 1.75 mmol d[Ca] might cause a worsening of GLS when compared to 1.25 mmol d[Ca], even using a cool dialysate. Our study is hypothesis generating, and more studies should be performed, as the exact mechanism remains to be elucidated. The clinical impact of using long-term high d[Ca] on ventricular dysfunction and whether this is related to myocardial stunning and long-term mortality in this population is still undefined.
Methods
Study Population
This was a single-center, single blind, and crossover study. The echocardiogram and the cardiac imaging analyses were blinded to patient details and treatment group allocations. Patients on thrice weekly conventional HD were enrolled after a recruitment period from July 2015 to April 2016. During the study no patient was receiving calcimimetic and one patient was submitted to parathyroidectomy 3 years previous to the study entry. The inclusion criteria were patients >18 years old who were on conventional HD for at least 6 months. Exclusion criteria were hospitalization in the last 6 months due to an active episode of decompensated heart failure or acute coronary syndrome, atrial fibrillation or another arrhythmia and poor echocardiographic image quality. The Local Institution Review Board at the Hospital da Clinicas da Universidade de São Paulo (Cappesq# 30284714.0.0000.0068) has approved the study protocol, which was conducted in accordance with the Declaration of Helsinki. All participants provided written informed consent to participate in the study. The protocol was registered at ClinicalTrials.gov (NCT02545426).
Study Procedures
Dialysis
The treatment duration was 4 hours, with a dialysate-flow rate of 800 mL/min and a blood-flow rate of 300 mL/min. All patients received unfractionated heparin as required and used high-flux polysulfone dialyzers (Fresenius® FX60; Fresenius Germany). The dialysate temperature was set at constant value of 35.5 °C. Twelve patients (63%) used arteriovenous fistulae as vascular access, and eight had a catheter. The dialysis prescription was adjusted to achieve a urea reduction ratio of 65% and a single pool Kt/V of 1.2 as described by Daugirdas and colleagues44. The ultrafiltration was set exactly the same in the two arms of the study for the same patient, and therefore was similar between interventions (3063 ± 534 mL vs. 3063 ± 534 mL, p = 1).
Echocardiographic Measurements
Two-dimensional echocardiography was performed in the left lateral decubitus position before dialysis and at peak dialysis in both situations (d[Ca] 1.25 and 1.75 mmol/L). A well-trained cardiologist obtained the following echocardiography images: the standard apical 2-, 3- and 4-chamber views before HD and at peak HD (60 minutes before the end of dialysis treatment). The images were obtained (1.5–3.6 MHz 3 S probe, Vivid I; GE Medical Systems, Sonigen, Germany) and were saved for subsequent analysis using a digitizing program (EchoPAC PC version 110.1.3, GE HealthCare, Tirat Carmel, Israel) by a physician totally blinded to the intervention and clinical data. This program uses speckle-tracking imaging (STI) to measure the myocardial strain. The region of interest was traced for each image at the end-systolic frame. Segmental and global values of left ventricular longitudinal myocardium strain were calculated. The operator manually adjusted segments that failed to track. GLS was calculated as the mean strain of all segments. The speckle patterns on a frame-by-frame basis were tracked using the EchoPAC tracking algorithm. Three consecutive heartbeats were analyzed for each image, and the peak strain was measured. A detailed description of STI analysis has been previously described45. The echocardiograms were evaluated according to the recommendations suggested by the American Society of Echocardiography46. The LVEF was calculated using Simpson’s biplane method. LV mass index was determined as the ratio of left ventricular mass to body surface area.
Laboratory Measurements
Blood samples were collected for biochemical analysis pre- and immediately post dialysis in the two interventions. All biochemical analyses were done according to the manufacturer’s instructions and usual techniques. Parathyroid hormone (PTH) was measured by chemiluminescence immunoassay (reference range = 11–65 pg/mL; Roche immunoassay analyzer, Roche Diagnostics, Germany). We have a performed a subanalysis of patients with PTH higher than 300 pg/ml, defined as patients with hyperparathyroidism since it was already demonstrated that these patients might have a distinct calcium balance when exposed to the same d[Ca]36. Troponin was measured by third-generation electrochemiluminescence assay (reference range = < 0.03 ng/mL; Roche Diagnostics). α-2-Macroglobulin was measured using a Multiplex Milliplex map kit – Human CVD Panel 3 (Acute Phase) – HCVD3MAG-67K (EMD Millipore Corporation, MA, USA®) assay.
Calcium Balance
Dialysate samples were collected from fresh dialysate and from a homogenous sample of spent dialysate collected during the 4-hour HD procedure to determine mass transfer of calcium. This procedure has been validated in the literature47,48.
Nutritional evaluation
Body mass index was calculated using the weight in kilograms divided by the square of the height in meters. Nutritional status was evaluated by the same observer, using the SGA classification technique as previously described49. Briefly, the SGA classification technique used historical data gathered from the patient on weight change, altered dietary intake, gastrointestinal symptoms influencing oral intake/absorption, and a physical examination. Patients were classified as well nourished, mild/moderately undernourished or severely undernourished.
Exposure
All patients were under regular HD with a d[Ca] of 1.75 mmol/L when were assigned to a random mid-week HD, with high (1.75 mmol/L) or low (1.25 mmol/L) d[Ca] and vive versa, in the subsequent week. The intervention was applied in only one session and patients returned to d[Ca] of 1.75 mmol/L afterward. Ultrafiltration was equal in both study arms.
Statistical analysis
The results are presented as the mean ± SD or median and (25–75) quartiles depending on the normality of the data. Comparisons between d[Ca] 1.25 and d[Ca] 1.75 mmol/L] were done using Student’s t test or Mann-Whitney test according to the Gaussian distribution. The correlation coefficients were Pearson or Spearman, depending on the normality of the data. Linear multiple regression analysis was performed with GLS at the peak of dialysis as a dependent variable and with the independent variables selected from the univariate analysis (p < 0.05). Due the lack of information about the influence of d[Ca] on GLS, sample size was calculated based on the data obtained with the first 15 patients included (mean difference in GLS between d[Ca] 1.25 and d[Ca] 1.75 mmol/L was 1.2 ± 1.7%). The required sample size to reach 5% of alpha error and 80% of power expected was 18 patients, in a paired design study. A p value < 0.05 was considered significant. Analyses were performed with the use of SPSS 21.0 (SPSS Inc., Chicago, Ill., USA) and GraphPad Prism® software version 7.0 (GraphPad Software, Inc., Calif., USA).
References
Go, A. S., Chertow, G. M., Fan, D., McCulloch, C. E. & Hsu, C. Y. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 351, 1296–1305, https://doi.org/10.1056/NEJMoa041031 (2004).
Kalantar-Zadeh, K., Block, G., Humphreys, M. H. & Kopple, J. D. Reverse epidemiology of cardiovascular risk factors in maintenance dialysis patients. Kidney Int 63, 793–808, https://doi.org/10.1046/j.1523-1755.2003.00803.x (2003).
Foley, R. N. & Parfrey, P. S. Cardiovascular disease and mortality in ESRD. J Nephrol 11, 239–245 (1998).
Burton, J. O., Jefferies, H. J., Selby, N. M. & McIntyre, C. W. Hemodialysis-induced repetitive myocardial injury results in global and segmental reduction in systolic cardiac function. Clin J Am Soc Nephrol 4, 1925–1931, https://doi.org/10.2215/CJN.04470709 (2009).
Zoccali, C. et al. Left ventricular systolic function monitoring in asymptomatic dialysis patients: a prospective cohort study. J Am Soc Nephrol 17, 1460–1465, https://doi.org/10.1681/ASN.2005111240 (2006).
Gorcsan, J. 3rd. & Tanaka, H. Echocardiographic assessment of myocardial strain. . J Am Coll Cardiol 58, 1401–1413, https://doi.org/10.1016/j.jacc.2011.06.038 (2011).
Liu, Y. W., Tsai, W. C., Su, C. T., Lin, C. C. & Chen, J. H. Evidence of left ventricular systolic dysfunction detected by automated function imaging in patients with heart failure and preserved left ventricular ejection fraction. J Card Fail 15, 782–789, https://doi.org/10.1016/j.cardfail.2009.05.006 (2009).
Mignot, A. et al. Global longitudinal strain as a major predictor of cardiac events in patients with depressed left ventricular function: a multicenter study. J Am Soc Echocardiogr 23, 1019–1024, https://doi.org/10.1016/j.echo.2010.07.019 (2010).
Stanton, T., Leano, R. & Marwick, T. H. Prediction of all-cause mortality from global longitudinal speckle strain: comparison with ejection fraction and wall motion scoring. Circ Cardiovasc Imaging 2, 356–364, https://doi.org/10.1161/CIRCIMAGING.109.862334 (2009).
Liu, Y. W. et al. Left ventricular systolic strain in chronic kidney disease and hemodialysis patients. Am J Nephrol 33, 84–90, https://doi.org/10.1159/000322709 (2011).
Selby, N. M., Burton, J. O., Chesterton, L. J. & McIntyre, C. W. Dialysis-induced regional left ventricular dysfunction is ameliorated by cooling the dialysate. Clin J Am Soc Nephrol 1, 1216–1225, https://doi.org/10.2215/CJN.02010606 (2006).
Jefferies, H. J., Virk, B., Schiller, B., Moran, J. & McIntyre, C. W. Frequent hemodialysis schedules are associated with reduced levels of dialysis-induced cardiac injury (myocardial stunning). Clin J Am Soc Nephrol 6, 1326–1332, https://doi.org/10.2215/CJN.05200610 (2011).
Sarafidis, P. A. et al. Haemodialysis acutely deteriorates left and right diastolic function and myocardial performance: an effect related to high ultrafiltration volumes? Nephrol Dial Transplant 32, 1402–1409, https://doi.org/10.1093/ndt/gfw345 (2017).
Sztajzel, J. et al. Effect of altered loading conditions during haemodialysis on left ventricular filling pattern. Eur Heart J 14, 655–661 (1993).
Virtanen, V. K., Saha, H. H., Groundstroem, K. W., Seppala, E. S. & Pasternack, A. I. Calcium infusion and left ventricular diastolic function in patients with chronic renal failure. Nephrol Dial Transplant 13, 384–388 (1998).
Nappi, S. E., Saha, H. H., Virtanen, V. K., Mustonen, J. T. & Pasternack, A. I. Hemodialysis with high-calcium dialysate impairs cardiac relaxation. Kidney Int 55, 1091–1096, https://doi.org/10.1046/j.1523-1755.1999.0550031091.x (1999).
Sztajzel, J. et al. Effects of dialysate composition during hemodialysis on left ventricular function. Kidney Int Suppl 41, S60–66 (1993).
Pun, P. H. et al. Cinacalcet, dialysate calcium concentration, and cardiovascular events in the EVOLVE trial. Hemodial Int 20, 421–431, https://doi.org/10.1111/hdi.12382 (2016).
Kyriazis, J. et al. Dialysate calcium profiling during hemodialysis: use and clinical implications. Kidney Int 61, 276–287, https://doi.org/10.1046/j.1523-1755.2002.00100.x (2002).
Dierkes, J. et al. Cardiac troponin T predicts mortality in patients with end-stage renal disease. Circulation 102, 1964–1969 (2000).
Liu, Y. W. et al. Association of left ventricular longitudinal strain with mortality among stable hemodialysis patients with preserved left ventricular ejection fraction. Clin J Am Soc Nephrol 8, 1564–1574, https://doi.org/10.2215/CJN.10671012 (2013).
Krishnasamy, R. et al. Left Ventricular Global Longitudinal Strain (GLS) Is a Superior Predictor of All-Cause and Cardiovascular Mortality When Compared to Ejection Fraction in Advanced Chronic Kidney Disease. PLoS One 10, e0127044, https://doi.org/10.1371/journal.pone.0127044 (2015).
Buchanan, C. et al. Intradialytic Cardiac Magnetic Resonance Imaging to Assess Cardiovascular Responses in a Short-Term Trial of Hemodiafiltration and Hemodialysis. J Am Soc Nephrol 28, 1269–1277, https://doi.org/10.1681/ASN.2016060686 (2017).
Tentori, F. et al. Mortality risk for dialysis patients with different levels of serum calcium, phosphorus, and PTH: the Dialysis Outcomes and Practice Patterns Study (DOPPS). Am J Kidney Dis 52, 519–530, https://doi.org/10.1053/j.ajkd.2008.03.020 (2008).
Kim, H. W. et al. Impact of Dialysate Calcium Concentration on Clinical Outcomes in Incident Hemodialysis Patients. Medicine (Baltimore) 94, e1694, https://doi.org/10.1097/MD.0000000000001694 (2015).
Jean, G. et al. Higher dialysate calcium is not associated with mortality in hemodialysis patients: results from the French ARNOS study. Nephrol Ther 9, 103–107, https://doi.org/10.1016/j.nephro.2012.08.003 (2013).
Pun, P. H., Horton, J. R. & Middleton, J. P. Dialysate calcium concentration and the risk of sudden cardiac arrest in hemodialysis patients. Clin J Am Soc Nephrol 8, 797–803, https://doi.org/10.2215/CJN.10000912 (2013).
Kyriazis, J. et al. Arterial stiffness alterations during hemodialysis: the role of dialysate calcium. Nephron Clin Pract 106, c34–42, https://doi.org/10.1159/000101482 (2007).
Verbeke, F. et al. Prognostic value of aortic stiffness and calcification for cardiovascular events and mortality in dialysis patients: outcome of the calcification outcome in renal disease (CORD) study. Clin J Am Soc Nephrol 6, 153–159, https://doi.org/10.2215/CJN.05120610 (2011).
Jimenez, Z. N. et al. High Dialysate Calcium Concentration May Cause More Sympathetic Stimulus During Hemodialysis. Kidney Blood Press Res 41, 978–985, https://doi.org/10.1159/000452601 (2016).
Rubinger, D., Backenroth, R. & Sapoznikov, D. Sympathetic nervous system function and dysfunction in chronic hemodialysis patients. Semin Dial 26, 333–343, https://doi.org/10.1111/sdi.12093 (2013).
National Kidney, F. K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis 42, S1–201 (2003).
Silva, B. C. et al. Hemodynamic behavior during hemodialysis: effects of dialysate concentrations of bicarbonate and potassium. Kidney Blood Press Res 39, 490–496, https://doi.org/10.1159/000368459 (2014).
Silva, B. C., Moyses, R. M., Silva, V. B., Freitas, G. R. & Elias, R. M. Parathyroidectomized patients have impaired capacity of peripheral vascular constriction during hemodialysis. Hemodial Int 20, 50–55, https://doi.org/10.1111/hdi.12309 (2016).
Ichimaru, K. & Horie, A. Microangiopathic changes of subepidermal capillaries in end-stage renal failure. Nephron 46, 144–149 (1987).
Karohl, C. et al. Effects of bone remodelling on calcium mass transfer during haemodialysis. Nephrol Dial Transplant 25, 1244–1251, https://doi.org/10.1093/ndt/gfp597 (2010).
deFilippi, C. R. et al. Frequency and cause of cardiac troponin T elevation in chronic hemodialysis patients from study of cardiovascular magnetic resonance. Am J Cardiol 100, 885–889, https://doi.org/10.1016/j.amjcard.2007.04.028 (2007).
Khan, N. A., Hemmelgarn, B. R., Tonelli, M., Thompson, C. R. & Levin, A. Prognostic value of troponin T and I among asymptomatic patients with end-stage renal disease: a meta-analysis. Circulation 112, 3088–3096, https://doi.org/10.1161/CIRCULATIONAHA.105.560128 (2005).
Wang, A. Y. et al. Troponin T, left ventricular mass, and function are excellent predictors of cardiovascular congestion in peritoneal dialysis. Kidney Int 70, 444–452, https://doi.org/10.1038/sj.ki.5001605 (2006).
Breidthardt, T. et al. Troponin T for the detection of dialysis-induced myocardial stunning in hemodialysis patients. Clin J Am Soc Nephrol 7, 1285–1292, https://doi.org/10.2215/CJN.00460112 (2012).
Zuidema, M. Y. & Dellsperger, K. C. Myocardial Stunning with Hemodialysis: Clinical Challenges of the Cardiorenal Patient. Cardiorenal Med 2, 125–133, https://doi.org/10.1159/000337476 (2012).
Fouque, D. et al. A proposed nomenclature and diagnostic criteria for protein-energy wasting in acute and chronic kidney disease. Kidney Int 73, 391–398, https://doi.org/10.1038/sj.ki.5002585 (2008).
Custodio, M. R. et al. Parathyroid hormone and phosphorus overload in uremia: impact on cardiovascular system. Nephrol Dial Transplant 27, 1437–1445, https://doi.org/10.1093/ndt/gfr447 (2012).
Daugirdas, J. T., Greene, T., Depner, T. A., Gotch, F. A. & Star, R. A. Relationship between apparent (single-pool) and true (double-pool) urea distribution volume. Kidney Int 56, 1928–1933, https://doi.org/10.1046/j.1523-1755.1999.00726.x (1999).
108.x.x, T. P. E. P. V. (2008). User Manual. Horten, Norway: GE Medical Systems, 2008. (2008).
American College of Cardiology Foundation Appropriate Use Criteria Task, F. et al. ACCF/ASE/AHA/ASNC/HFSA/HRS/SCAI/SCCM/SCCT/SCMR 2011 Appropriate Use Criteria for Echocardiography. A Report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, American Society of Echocardiography, American Heart Association, American Society of Nuclear Cardiology, Heart Failure Society of America, Heart Rhythm Society, Society for Cardiovascular Angiography and Interventions, Society of Critical Care Medicine, Society of Cardiovascular Computed Tomography, and Society for Cardiovascular Magnetic Resonance Endorsed by the American College of Chest Physicians. J Am Coll Cardiol 57, 1126–1166, https://doi.org/10.1016/j.jacc.2010.11.002 (2011).
Argiles, A. et al. Precise quantification of dialysis using continuous sampling of spent dialysate and total dialysate volume measurement. Kidney Int 52, 530–537 (1997).
Melo, N. C., Moyses, R. M., Elias, R. M. & Castro, M. C. Reprocessing high-flux polysulfone dialyzers does not negatively impact solute removal in short-daily online hemodiafiltration. Hemodial Int 18, 473–480, https://doi.org/10.1111/hdi.12126 (2014).
Visser, R., Dekker, F. W., Boeschoten, E. W., Stevens, P. & Krediet, R. T. Reliability of the 7-point subjective global assessment scale in assessing nutritional status of dialysis patients. Adv Perit Dial 15, 222–225 (1999).
Acknowledgements
We thank the Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP), which provided the grant responsible for the echocardiogram equipment (1.5–3.6 MHz 3 S probe, Vivid I; GE Medical Systems, Sonigen, Germany). We are grateful to the staff and patients of the Dialysis Service for their participation in the study. Research in the laboratory of RM is supported by CNPQ, Conselho Nacional de Desenvolvimento Científico e Tecnológico (Grant Number 303899/2016-6).
Author information
Authors and Affiliations
Contributions
Research idea and study design: V.S., T.M., L.D., R.M., R.E.; Data acquisition: V.S., T.M., T.B.; Data analysis/interpretation: V.S., T.M., T.B., B.S., F.G., W.D., L.D., R.M., R.E.; Statistical analysis: R.E.; Supervision or mentorship: L.D., R.M., R.E. Each author contributed important intellectual content during manuscript drafting or revision and accepts accountability for the overall work by ensuring that questions pertaining to the accuracy or integrity of any portion of the work are appropriately investigated and resolved.
Corresponding author
Ethics declarations
Competing Interests
The authors declare no competing interests.
Additional information
Publisher’s note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Silva, V.B., Macedo, T.A., Braga, T.M.S. et al. High Dialysate Calcium Concentration is Associated with Worsening Left Ventricular Function. Sci Rep 9, 2386 (2019). https://doi.org/10.1038/s41598-019-38887-y
Received:
Accepted:
Published:
DOI: https://doi.org/10.1038/s41598-019-38887-y
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.